Sovereign Capital Partners Invests in Bioscript

Bioscript Group (backed by Sovereign Capital Partners) Acquires Meridian HealthComms

April 19, 2022

Healthcare Services

Bioscript Group, a Sovereign Capital Partners-backed healthcare communications platform headquartered in Macclesfield, has acquired Meridian HealthComms. The deal is Bioscript's third acquisition since Sovereign backed the management team in March 2021 and expands the group's geographic footprint and service capabilities in medical communications, regulatory writing and market access.

Sovereign Capital Partners Invests in AquaQ Analytics

May 6, 2021

Data & Analytics

Sovereign Capital Partners has completed a significant investment in AquaQ Analytics, a Belfast-based specialist data analytics and data science services firm that supports global financial institutions. The investment will partner with AquaQ's founders and management to expand the company's international presence and broaden its data analytics and software service offerings.

Ampersand Capital Partners Invests in AnaBios Corporation

June 7, 2022

Healthcare Services

Ampersand Capital Partners has made a growth equity investment in San Diego-based AnaBios Corporation, a preclinical contract research organization specializing in translational research using human tissues. The investment will be used to expand AnaBios’s capabilities, therapeutic area coverage and global reach to support more successful drug discovery and development programs.

Sovereign Capital Partners Backs Skerritts in £55m Wealth Management Investment

March 10, 2021

Wealth Management

Sovereign Capital Partners has invested £55m to back Skerritts, an independent financial advisory and wealth management firm headquartered in Hove, England. The investment will partner the existing management team to accelerate organic growth and fund an acquisitive "buy & build" strategy to expand Skerritts' geographic footprint and capabilities.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

Ampersand Capital Partners Invests in BioEcho Life Sciences

March 1, 2022

Biotechnology

Ampersand Capital Partners made a minority growth equity investment in Cologne-based BioEcho Life Sciences to support the company's global expansion, new product launches, and expansion of its direct salesforce. As part of the transaction Ampersand appointed Frank Witney and Arya Mehrabanzad to BioEcho's board; financial terms were not disclosed.